10-4-7　ⓔ文献

  1. Sada KE, Yamamura M, et al: Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody–associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther, 2014; 16: R101.

  2. Hirayama K, Kobayashi M, et al: Pulmonary involvements of anti–neutrophil cytoplasmic autoantibody–associated renal vasculitis in Japan. Nephrol Dial Transplant, 2015; 30: i83–i93.

  3. Greco A, Rizzo MI, et al: Churg–Strauss syndrome. Autoimmun Rev, 2015; 14: 341–348.

  4. Lanham JG, Elkon KB, et al: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore), 1984; 63: 65–81.

  5. Pagnoux C, Guillevin L: Churg–Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol, 2010; 22: 21–28.

  6. Vaglio A, Buzio C, et al: Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art. Allergy, 2013; 68: 261–273.

  7. Sada KE, Amano K, et al: A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) in Japan. Mod Rheumatol, 2014; 24: 640–644.

  8. Szczeklik W, Sokolowska B, et al: Pulmonary findings in Churg–Strauss syndrome in chest X–rays and high resolution computed tomography at the time of initial diagnosis. Clin Rheumatol, 2010; 29: 1127–1134.

  9. Taniguchi M, Tsurikisawa N, et al: Treatment for Churg–Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol Int, 2007; 56: 97–103.

  10. Wechsler ME, Akuthota P, et al: Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med, 2017; 376: 1921–1932.

  11. Saus J, Wieslander J, et al: Identification of the Goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem, 1988; 263: 13374–13380.

  12. Bernis P, Hamels J, et al: Remission of Goodpasture’s syndrome after withdrawal of an unusual toxic. Clin Nephrol, 1985; 23: 312–317.

  13. Pillai S, Perugino C, et al: Immune mechanisms of fibrosis and inflammation in IgG4–related disease. Curr Opin Rheumatol, 2020; 32: 146–151.

  14. Masamune A, Kikuta K, et al: Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol, 2020; 55: 462–470.

  15. Matsui S, Yamamoto H, et al: Proposed diagnostic criteria for IgG4–related respiratory disease. Respir Investig, 2016; 54: 130–132.

  16. Inoue D, Zen Y, et al: Immunoglobulin G4–related lung disease: CT findings with pathologic correlations. Radiology, 2009; 251: 260–270.

  17. Matsui S, Hebisawa A, et al: Immunoglobulin G4–related lung disease: clinicoradiological and pathological features. Respirology, 2013; 18: 480–487.

  18. Zen Y, Nakanuma Y: IgG4–related disease: a cross–sectional study of 114 cases. Am J Surg Pathol, 2010; 34: 1812–1819.